Overview
Top Medical Research Studies
By examining this transformation, we looked into its effects on calcium entry in vascular smooth muscle cells (VSMCs) as well as its binding affinity to blood pressure receptors. Through laboratory experiments using both spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY), we found that those treated with PLP experienced a significant drop in blood pressure, while the control group showed an increase after receiving angiotensin II.
This suggests that PLP could be an effective, low-cost option for managing hypertension, potentially offering a new path for treatment. Increasing PLP intake could help hypertensive individuals manage their condition more effectively and affordably.
Our findings showed that pyridoxamine significantly reduced the heart-related harm often associated with DOX treatment. Specifically, it helped in preserving the heart's structure and function, limiting the development of conditions like dilated cardiomyopathy. Furthermore, pyridoxamine appeared to mitigate inflammation, fibrosis, and oxidative stress, all of which can worsen heart health over time.
The treatment notably protected against iron-related cell death, restoring healthier balance in iron levels and improving overall heart condition at the genetic level. This suggests that pyridoxamine could serve as a promising new strategy to protect against heart damage in patients undergoing chemotherapy.
To investigate this, we conducted experiments measuring the effects of VB6 on human umbilical vein endothelial cells, a type of cell involved in blood vessel formation. We noticed that VB6 not only increased cell migration and tubule formation but also activated AMP-activated protein kinase (AMPK), a key player in cellular energy regulation. This activation led to a positive chain reaction that enhanced the production of vascular endothelial growth factor A, which aids in blood vessel growth.
Perhaps most exciting is our finding from in vivo studies, where long-term VB6 supplementation in mice significantly improved heart functions, increased new blood vessel formation, and reduced inflammatory cytokines after AMI. This suggests that VB6 serves as a strong ally in promoting heart recovery after ischemic injury. Our results indicate that adding VB6 to treatment plans could be beneficial in preventing cardiac dysfunction following heart attacks.
Most Useful Reviews
Medical Researches
- All Researches
During testing, we found that vitamin B6 effectively reduced ST-segment elevation on ECG and lowered heart rate related to the vasopressin-induced angina. Notably, it showed a dose-dependent response, with specific doses of 5 mg and 7 mg per kilogram proving particularly effective.
Interestingly, when we compared pyridoxine to amlodipine, another cardiovascular drug, we observed that pyridoxine not only performed better at reducing cardiac enzymes linked to heart damage but also suggests a novel approach to preventing coronary heart disease. However, combining pyridoxine with amlodipine raised concerns about increased adverse cardiovascular events, indicating that while pyridoxine may enhance heart protection, pairing it with certain medications could complicate treatment.
Given these findings, we believe that vitamin B6 at optimal doses may hold promise for heart disease prevention and deserves further exploration in clinical settings.
By examining this transformation, we looked into its effects on calcium entry in vascular smooth muscle cells (VSMCs) as well as its binding affinity to blood pressure receptors. Through laboratory experiments using both spontaneously hypertensive rats (SHR) and Wistar Kyoto rats (WKY), we found that those treated with PLP experienced a significant drop in blood pressure, while the control group showed an increase after receiving angiotensin II.
This suggests that PLP could be an effective, low-cost option for managing hypertension, potentially offering a new path for treatment. Increasing PLP intake could help hypertensive individuals manage their condition more effectively and affordably.
By assessing the cardiac function using echocardiography, we were able to track how the inclusion of vitamin B-6 impacted various heart issues related to HFpEF. Our findings were quite promising: when vitamin B-6 was administered alongside the HFpEF diet, we saw significant improvements in several key areas.
The E/E' ratio—a measure of heart function—dropped considerably, from 42.0 down to 21.6, while the E/A ratio improved, indicating better heart operation. Moreover, the mice displayed enhanced exercise capacity. However, it was interesting to note that these positive outcomes vanished in mice lacking the DOK3 protein, suggesting that vitamin B-6 plays a role in regulating signaling pathways that affect the function of heart macrophages.
Overall, our study indicates that vitamin B-6 could be a valuable therapeutic approach to mitigate the effects of HFpEF by preventing harmful changes in macrophage function, thereby supporting heart health.
Our research included a randomized, double-blind, placebo-controlled trial with 54 participants aged between 40 and 75, all of whom had elevated homocysteine and moderate LDL-C levels. Over a six-month period, those receiving a combination of methylfolate, pyridoxal-5'-phosphate (vitamin B6), and methylcobalamin showed a significant reduction in both homocysteine by 30% and LDL-C by 7.5%, compared to those who received a placebo.
Particularly interesting were the findings regarding the subgroup of participants with homozygous minor allele polymorphisms, who experienced even larger decreases in homocysteine levels and LDL-C compared to mixed allele carriers. While vitamin B6 was part of the effective combination, we must note that its individual effect on cardiovascular disease remains uncertain, as the study primarily evaluates the combined effect of the B vitamins.
Our findings revealed that pyridoxamine significantly improved heart function in the rats treated with doxorubicin. Specifically, the left ventricular ejection fraction, which indicates how well the heart pumps blood, was notably higher in rats receiving pyridoxamine. Additionally, we found that pyridoxamine reduced the heart's end-systolic volume, suggesting it helped maintain heart health during doxorubicin treatment.
On the other hand, when we looked at the effects of doxorubicin on cancer cells in the lab, pyridoxamine did not change the drug's effectiveness. Doxorubicin still reduced cell viability and increased cell death in the tumor cells, which indicates that while pyridoxamine may protect the heart, it does not interfere with the drug's ability to fight cancer.
In conclusion, pyridoxamine appears to be a promising option for safeguarding heart health during cancer treatments with doxorubicin, without affecting the drug's anticancer properties.
User Reviews
- All Reviews
- Positive Reviews
- Negative Reviews
Frequently Asked Questions
Cardiovascular disease (CVD) is a broad term that encompasses a range of heart and blood vessel disorders. This can include conditions such as coronary artery disease, which leads to heart attacks; cerebrovascular disease that results in strokes; and peripheral artery disease affecting blood flow to the limbs. The key risk factors for CVD often include high blood pressure, high cholesterol, obesity, smoking, a sedentary lifestyle, and diabetes. By identifying and managing these risk factors, individuals can significantly reduce their likelihood of developing cardiovascular problems.
Prevention and treatment strategies often involve lifestyle modifications such as adopting a heart-healthy diet rich in fruits, vegetables, whole grains, and lean proteins, alongside engaging in regular physical activity. In some cases, medications might be necessary to control blood pressure or cholesterol levels. Regular check-ups with a healthcare provider are essential for monitoring heart health, especially for individuals with a family history of CVD. Understanding the signs and symptoms of cardiovascular issues—like chest pain, shortness of breath, or fatigue—can help in seeking timely medical attention, ultimately leading to better outcomes.
Vitamin B refers to a group of eight essential water-soluble vitamins that play a vital role in various physiological functions in the body. These vitamins include B1 (thiamine), B2 (riboflavin), B3 (niacin), B5 (pantothenic acid), B6 (pyridoxine), B7 (biotin), B9 (folate, or folic acid), and B12 (cobalamin). Each of these vitamins contributes to key processes such as energy metabolism, red blood cell formation, cognitive function, and the synthesis of DNA. Because they are water-soluble, any excess amounts are not stored in the body and can be lost through urine, making regular dietary intake important.
Foods rich in B vitamins include whole grains, meat, eggs, dairy products, legumes, seeds, nuts, and dark leafy greens. Deficiencies can lead to a host of health issues, including fatigue, anemia, cognitive decline, and skin problems. Supplements are available and can be beneficial, especially for individuals with specific dietary restrictions, such as vegetarians or those with certain medical conditions that affect nutrient absorption. Always consult a healthcare professional before starting any new supplement regimen to assess individual needs and avoid potential negative interactions.
Vitamin B complex plays a crucial role in maintaining overall health, and certain B vitamins, such as B6, B12, and folate, have been studied for their potential impact on cardiovascular health. These vitamins help lower homocysteine levels—an amino acid linked to an increased risk of heart disease. Elevated homocysteine levels may damage blood vessels and promote clot formation, leading to cardiovascular complications. By ensuring adequate intake of these vitamins through diet or supplementation, individuals might support vascular health and potentially lower their risk of cardiovascular disease.
However, while there is evidence supporting the role of B vitamins in cardiovascular health, it is essential to approach supplementation with caution. Recent studies suggest that taking high doses of B vitamins does not significantly reduce cardiovascular disease risk in people who already have normal levels of these nutrients. Instead, a well-rounded diet rich in leafy greens, beans, whole grains, and fortified cereals is the best way to ensure you receive adequate B vitamins. For those with specific dietary restrictions or health conditions, consulting with a healthcare provider before starting any vitamin regimen is advisable.
Based on user reviews, many individuals report seeing results in lowering their homocysteine levels, which are linked to cardiovascular disease, within a timeframe of 1.5 to 3 months. For example, one user mentioned that their husband's homocysteine level dropped significantly from 22 to 8 after using the supplement for this duration (Read Review). Another contributor echoed this timeframe, indicating it took at least 1.5 months to notice improvements while using the supplement (Read Review).
In general, users emphasize the importance of consistent use and proper dosage to achieve desired effects on cardiovascular health. It is recommended to dissolve one tablet an hour after breakfast to optimize absorption (Read Review). Monitoring homocysteine levels annually is suggested, as this can have serious implications for overall health (Read Review). However, individual responses may vary, and some users recommend continuing the supplement beyond the initial improvement period for the best long-term results.
Based on recent research, there appears to be a significant link between vitamin B6 and cardiovascular health. Various studies suggest that vitamin B6, particularly in its active form Pyridoxal 5'-Phosphate (PLP), can positively influence cholesterol levels—specifically helping to lower LDL (bad cholesterol) and potentially raise HDL (good cholesterol) levels. For instance, one study highlighted that higher PLP levels correlated with a notable decrease in LDL cholesterol, indicating that vitamin B6 may play a role in cardiovascular protection, especially for individuals at greater risk, such as those with diabetes [1]. Moreover, another study pointed out that vitamin B6 supplementation could bolster heart recovery after a myocardial infarction by promoting new blood vessel formation [3].
However, it's essential to approach these findings with caution. A study observed a concerning association between vitamin B6 and an increased risk of stroke, suggesting that the relationship isn't straightforward [7]. While certain studies support the use of vitamin B6 to enhance cardiovascular health, it's vital to consider its complex interactions with other health factors and to maintain a balanced intake of various vitamins for optimal results. Thus, while vitamin B6 holds promise, further clinical trials are necessary to clarify its role and potential as a preventive measure against cardiovascular disease.
Users have shared positive experiences regarding improvements in their homocysteine levels after using the supplement, with many noting significant drops within 1.5 to 3 months. One reviewer highlighted how their husband's level decreased dramatically from 22 to 8, attributing this change to the supplement (Read Review). Another user confirmed a similar experience, noting that consistent use helped them manage their elevated levels effectively, which was crucial for avoiding conditions associated with cardiovascular disease (Read Review).
Additionally, users appreciated the ease of use and pleasant taste of the tablets, recommending dissolving one tablet an hour after breakfast for optimal absorption of B12 and B9 (Read Review). A common theme among reviews is the link between improved nutrient levels and overall health, with users stressing the need for regular testing and continued usage of the supplement for lasting results. While these accounts are promising, it’s important to remember that individual results may vary, and what works well for one person may not yield the same benefits for another.
Based on user reviews, many individuals reported positive outcomes when combining this supplement with heightened focus on the methylated forms of vitamins B9 and B12. Users emphasized that these forms are crucial for effective absorption and may enhance the supplement's efficacy in lowering homocysteine levels, which are linked to cardiovascular disease risks (Read Review). Reviewers have highlighted that optimal results, such as significant drops in homocysteine levels (e.g., from 22 to 8), often followed consistent use alongside careful attention to dosage and timing—specifically, dissolving the tablet an hour after breakfast to maximize absorption (Read Review).
Moreover, users encouraged combining this supplement with regular monitoring of one’s homocysteine levels as part of a broader strategy to manage cardiovascular health. Being aware of nutrient deficiencies, particularly in B12 and folate, was seen as vital, as these deficiencies can exacerbate cardiovascular risks (Read Review). Overall, the consensus among reviewers was that for best results, this supplement should be considered within the context of a holistic health plan, which may include other supportive dietary strategies.
Based on user reviews, many individuals report the significance of maintaining the right dosage of Vitamins B12 and B9 (folate) to effectively lower elevated homocysteine levels, which are directly linked to cardiovascular disease. One user detailed how their husband successfully brought his homocysteine level down from 22 to 8 after adhering to a regimen of one tablet daily, dissolved an hour after breakfast for 1.5 to 3 months, recommending this specific practice for optimal absorption and taste (Read Review). The consensus among reviewers suggests that the ideal target for homocysteine levels should be between 5 and 6, underlining the importance of monitoring these levels regularly (Read Review).
Moreover, users emphasized the necessity of using methylated forms of these vitamins for better efficacy in lowering homocysteine for cardiovascular health (Read Review). The importance of vitamin B for normalizing homocysteine metabolism is also highlighted as a critical component in preventing serious health issues, with many advocating for annual testing to stay informed about their levels (Read Review). Overall, consistency with the appropriate dose appears to be key to managing cardiovascular disease risk associated with high homocysteine levels.
Our results showed that higher PLP levels were associated with lower levels of LDL cholesterol, suggesting that vitamin B6 might play a role in reducing the risk of cardiovascular issues. In fact, a single unit increase in PLP was linked to a significant decrease of around 17.7% in LDL cholesterol levels. Additionally, we found that PLP levels were positively correlated with HDL cholesterol levels, indicating that higher PLP could lead to an improvement in good cholesterol.
Notably, these associations seemed stronger in specific groups, such as diabetic individuals and those who abstain from alcohol. This points to a potential for vitamin B6 supplementation as a preventive measure against cardiovascular and metabolic diseases, particularly for those at higher risk. Overall, our findings illuminate vitamin B6 as a promising player in heart health discussions, particularly through its effects on cholesterol levels.
To investigate this, we conducted experiments measuring the effects of VB6 on human umbilical vein endothelial cells, a type of cell involved in blood vessel formation. We noticed that VB6 not only increased cell migration and tubule formation but also activated AMP-activated protein kinase (AMPK), a key player in cellular energy regulation. This activation led to a positive chain reaction that enhanced the production of vascular endothelial growth factor A, which aids in blood vessel growth.
Perhaps most exciting is our finding from in vivo studies, where long-term VB6 supplementation in mice significantly improved heart functions, increased new blood vessel formation, and reduced inflammatory cytokines after AMI. This suggests that VB6 serves as a strong ally in promoting heart recovery after ischemic injury. Our results indicate that adding VB6 to treatment plans could be beneficial in preventing cardiac dysfunction following heart attacks.
Our findings revealed a concerning aspect of vitamin B6: its association with an increased risk of large-artery stroke. While it’s essential to note this association, we must interpret these results cautiously due to the limited number of genetic markers studied for vitamin B6.
Thus, while vitamin B6 was part of our evaluation, the evidence suggesting a harmful effect on cardiovascular events is not definitive. Further investigation is needed to clarify its role and determine if it should be a primary focus in stroke prevention efforts.
References
- Zhang RY, Chen Y, Yan XQ, Zhang Y, Zhou H, et al. Association of pyridoxal 5'-phosphate (PLP) with lipid profiles: a population-based cohort study. Front Nutr. 2025;12:1545301. doi:10.3389/fnut.2025.1545301
- Al-Khawlani MA, Al-Madhagi WM, Sabati AM, ALomaisi SAMA, Al-Najar M. Protective effects of pyridoxine, amlodipine, and their combination in a vasopressin-induced angina model in rats. Naunyn Schmiedebergs Arch Pharmacol. 2025. doi:10.1007/s00210-025-03905-6
- Wang XQ, Yin S, Wang QW, Bai WW, Tan RH, et al. Vitamin B6 allosterically activates AMPK to promote postischemic angiogenesis in mice. Eur J Pharmacol. 2025;993:177413. doi:10.1016/j.ejphar.2025.177413
- Lellig M, Rodríguez M, López-Baltanás R, Hermann J, Wollenhaupt J, et al. Pyridoxal-5'-phosphate: A cost-effective treatment candidate for hypertensive patients?. J Intern Med. 2024;296:435. doi:10.1111/joim.20015
- Rafinezhad M, Kheirouri S, Abbasnezhad M, Alizadeh M. What Dietary Vitamins and Minerals Might Be Associated with Paraoxonase-1 Serum Levels in Patients with Coronary Artery Disease?. Biol Trace Elem Res. 2024. doi:10.1007/s12011-024-04382-3
- Ren W, Li Y, Lu C, Liu S, Shao Y, et al. Comprehensive assessment on the association of dietary vitamins with all-cause and cardiovascular mortality among individuals with prediabetes: evidence from NHANES 1999-2018. Food Funct. 2024;15:10037. doi:10.1039/d4fo02893g
- Dong G, Xu W, Xu L. Causal Effect of Macronutrient and Micronutrient Intake on Stroke: A Two-Sample Mendelian Randomization Study. Nutrients. 2024;16. doi:10.3390/nu16172818
- Li B, Hu M, Ma Y, Sun X, Wu D, et al. Association between Vitamin E, Vitamin B6, and Vitamin B12 with coronary heart disease. Sci Rep. 2024;14:19960. doi:10.1038/s41598-024-68413-8
- Song JW, Zhang ZS, Chen L, Wang QW, Xu JY, et al. Vitamin B-6 Prevents Heart Failure with Preserved Ejection Fraction Through Downstream of Kinase 3 in a Mouse Model. J Nutr. 2024;154:3031. doi:10.1016/j.tjnut.2024.08.006
- Pokushalov E, Ponomarenko A, Bayramova S, Garcia C, Pak I, et al. Effect of Methylfolate, Pyridoxal-5'-Phosphate, and Methylcobalamin (Soloways) Supplementation on Homocysteine and Low-Density Lipoprotein Cholesterol Levels in Patients with Methylenetetrahydrofolate Reductase, Methionine Synthase, and Methionine Synthase Reductase Polymorphisms: A Randomized Controlled Trial. Nutrients. 2024;16. doi:10.3390/nu16111550
- Wang P, Huang J, Xue F, Abuduaini M, Tao Y, et al. Associations of serum vitamin B6 status with the risks of cardiovascular, cancer, and all-cause mortality in the elderly. Front Immunol. 2024;15:1354958. doi:10.3389/fimmu.2024.1354958
- Haesen S, Verghote E, Heeren E, Wolfs E, Deluyker D, et al. Pyridoxamine Attenuates Doxorubicin-Induced Cardiomyopathy without Affecting Its Antitumor Effect on Rat Mammary Tumor Cells. Cells. 2024;13. doi:10.3390/cells13020120
- Haesen S, Jager MM, Brillouet A, de Laat I, Vastmans L, et al. Pyridoxamine Limits Cardiac Dysfunction in a Rat Model of Doxorubicin-Induced Cardiotoxicity. Antioxidants (Basel). 2024;13. doi:10.3390/antiox13010112
- Liang Z, Fan F, Liu B, Li K, Chen H, et al. Association Between Serum Folate Concentrations and 10-Year Stroke Risk in a Prospective Community Cohort: Mediation and Interaction Analyses. Nutrients. 2024;17. doi:10.3390/nu17010159
- Palchetti CZ, Gonçalves NG, Suemoto CK, Santos IS, Lotufo PA, et al. Serum folate levels, but not vitamin B12, are associated with slower progression in carotid intima-media thickness in a population exposed to mandatory folic acid fortification. Clin Nutr ESPEN. 2025;65:144. doi:10.1016/j.clnesp.2024.11.034
- Prasad K. Atherogenic Effect of Homocysteine, a Biomarker of Inflammation and Its Treatment. Int J Angiol. 2024;33:262. doi:10.1055/s-0044-1788280
- Kaushik A, Bhattacharjee D, Chaudhary V, Dahal S, Devi NK, et al. Hypertension and global DNA methylation: a population-based study in rural, Punjab, India. Sci Rep. 2024;14:25826. doi:10.1038/s41598-024-77437-z
- Siddiqi SM, Liu L, Du Y, Song Y, Chen P, et al. Association of MTHFR C677T, MTHFRA1298C, and MTRRA66G Gene Polymorphisms with Hyperhomocysteinemia and Its Modulation by the Combined Effect of Vitamin B12 and Folate in Chinese Population with Hypertension. J Nutr. 2024. doi:10.1016/j.tjnut.2024.09.003
- Liang X, Huang D, Bi Y, He Y, Mao T, et al. The impact of folic acid/VB12 deficiency on essential hypertension in children and adolescents: from a nested case-control and a cohort study. J Hum Hypertens. 2024;38:844. doi:10.1038/s41371-024-00955-w
